Rituximab
- Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patients. Boumans et al., Rheumatology (Oxford). 2013 Aug;52(8):1462-6.
- A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. van den Bemt et al., Ann Rheum Dis 2009; 68(8):1368-9.
- Clinical response, pharmacokinetics, development of human anti-chimeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis. Thurlings et al., Ann Rheum Dis 2009 Jul 12.
- Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study. Pijpe et al., Arthritis Rheum 2005; 52(9):2740-50.
